Sirna Targeting Fas Protects Donor Liver Against Cold Preservation and Ischemic Reperfusion Injury in Rat Liver Transplantation

LI Xi,ZHANG Jun-feng,GUO Wei-pin,LU Min-qiang,YANG Yang,XU Chi,LI Hua,WANG Gen-shu,HU Bin,CHI Xin-jin,CHEN Gui-hua
DOI: https://doi.org/10.3321/j.issn:1000-4718.2008.02.023
2008-01-01
Abstract:AIM: To investigate the silencing effect of fas siRNA to alleviate ischemic-reperfusion(I/R) injury in liver transplantation.METHODS: Three pairs of 21-nt synthesized fas siRNAs were transfected into BRL cells respectively for evaluation of silence efficacy,and the most effective fas siRNA was chosen in vivo for experiment.In cold preservation experiment,siRNA was transfected in vivo by hydrodynamics method.After 48 h,livers of fas siRNA group and control group were harvested and cold preserved,and cell apoptosis and fas expression was evaluated at 2,4 and 6 h.Orthotopic liver transplantation was performed in fas siRNA group and blank control group.At 1,3,6,12 and 24 h after transplantation,blood and liver samples were collected for evaluation of serum ALT levels,Fas protein and mRNA expression,and apoptosis by TUNEL staining.RESULTS: fas siRNA2,which began at nt 315,inhibited fas gene expression much more than other siRNAs.As to cold preservation,apoptosis index(AI) and fas expression in fas siRNA group was lower than that in control group at each checked point(P0.01).At 1,3,6,12,and 24 h after blood reperfusion of liver transplantation,the serum ALT level in fas siRNA group was much less than that in control group.The cell apoptosis in fas siRNA group was substantially decreased,and the expressions of fas mRNA and protein were dramatically reduced.CONCLUSION: fas-mediated apoptosis plays an important role in I/R injury of rat liver transplantation.Silencing fas by siRNA holds therapeutic promise to limit I/R injury.
What problem does this paper attempt to address?